Quotes 5-day view Delayed Xetra
09/14/2020
09/15/2020
09/16/2020
09/17/2020
09/18/2020
Date
123.15(c)
122.6(c)
124.3(c)
124.05(c)
126.75 Last
310 745
466 755
415 347
276 406
783 630 Volume
+0.94% -0.45% +1.39% -0.20% +2.18% Change
Sales 2020
17 299 M 20 480 M 20 480 M
Net income 2020
1 688 M 1 998 M 1 998 M
Net Debt 2020
10 712 M 12 681 M 12 681 M
P/E ratio 2020
31,3x
Yield 2020
1,07%
Sales 2021
18 153 M 21 491 M 21 491 M
Net income 2021
2 108 M 2 495 M 2 495 M
Net Debt 2021
8 815 M 10 436 M 10 436 M
P/E ratio 2021
24,9x
Yield 2021
1,14%
Capitalization
53 934 M 63 767 M 63 852 M
EV / Sales 2020
3,74x
EV / Sales 2021
3,46x
Nbr of Employees
57 523
Free-Float
29,7%
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:
- pharmaceutical products (41.6%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;
- solutions and products for scientific and biotechnological research...
Notations Surperformance© of Merck KGaA
Trading Rating : Investor Rating :
All news about MERCK KGAA
News in other languages on MERCK KGAA
Analyst Recommendations on MERCK KGAA
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends MERCK KGAA
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
22
Average target price
120,57 €
Last Close Price
124,05 €
Spread / Highest target
20,9%
Spread / Average Target
-2,81%
Spread / Lowest Target
-25,8%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capitalization (M$)
MERCK KGAA 17.75% 63 767
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
